Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Converting negative symptom dimension scores across SANS and PANSS.

Schizophrenia research·2026
Same author

AI-associated delusions: terminology.

The lancet. Psychiatry·2026
Same author

Minimally Invasive Versus Open Total Hysterectomy: From Practice Variability to a Decision Algorithm.

Life (Basel, Switzerland)·2026
Same author

Strategic Challenges of Hysterectomy in Benign Gynecological Pathology - Perspectives from a Systematic Review.

Chirurgia (Bucharest, Romania : 1990)·2026
Same author

NeuroMark-SZ: A Holistic Resting-State-fMRI-Based Model for Divergent Functional Circuitry in Schizophrenia.

bioRxiv : the preprint server for biology·2026
Same author

Recurrence patterns in primary urethral carcinoma: Prognostic impact of inguinal and pelvic lymphadenectomy.

Urologic oncology·2026

Related Experiment Video

Updated: Jul 5, 2025

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
13:19

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Published on: November 2, 2013

16.6K

How to Integrate Prostate Cancer Biomarkers in Urology Clinical Practice: An Update.

Catalin Baston1,2, Adrian Preda2, Alexandru Iordache2

  • 1Department of Nephrology, Urology, Immunology and Immunology of Transplant, Dermatology, Allergology, Faculty of Medicine, "Carol Davila" University of Medicine and Pharmacy, 050474 Bucharest, Romania.

Cancers
|January 23, 2024
PubMed
Summary

Biomarkers aid in managing prostate cancer by improving diagnosis and treatment strategies. This review highlights evidence supporting biomarker use in clinical decisions for localized and advanced prostate cancer.

Keywords:
biomarkersclinical practiceindividualized medicinepersonalized medicineprostate cancer genetics

More Related Videos

Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking
07:34

Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking

Published on: November 17, 2023

690
A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound
06:08

A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound

Published on: March 21, 2025

230

Related Experiment Videos

Last Updated: Jul 5, 2025

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
13:19

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Published on: November 2, 2013

16.6K
Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking
07:34

Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking

Published on: November 17, 2023

690
A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound
06:08

A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound

Published on: March 21, 2025

230

Area of Science:

  • Uro-oncology
  • Medical diagnostics

Background:

  • Prostate cancer management is complex due to numerous treatments and evolving understanding.
  • Current risk stratification systems lack personalization, impacting clinical decisions and patient outcomes.
  • Disease heterogeneity within prognostic groups challenges effective management strategies.

Purpose of the Study:

  • To review scientific evidence supporting the clinical utility of biomarkers in prostate cancer diagnosis and management.
  • To focus on biomarkers recommended by urological societies and included in uro-oncological guidelines.
  • To address challenging management scenarios for both localized and advanced prostate cancer.

Main Methods:

  • Literature review of scientific evidence on prostate cancer biomarkers.
  • Analysis of biomarkers considered in current uro-oncological guidelines.
  • Focus on biomarkers relevant to diagnosis and complex management strategies.

Main Results:

  • Several biomarkers show promise in aiding clinical decision-making for prostate cancer.
  • Biomarker evidence supports their integration into diagnostic processes.
  • Specific biomarkers assist in guiding management for localized and advanced disease.

Conclusions:

  • Biomarkers are crucial tools for personalized prostate cancer management.
  • Evidence supports the use of guideline-recommended biomarkers in clinical practice.
  • Utilizing biomarkers can optimize treatment strategies and improve oncological outcomes.